{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:34:18Z","timestamp":1793021658393,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.gofs.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:32:52Z","timestamp":1785195172000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirine et grossesse \u00e0 l\u2019\u00e8re du d\u00e9pistage pr\u00e9coce au 1er trimestre\u00a0: efficacit\u00e9, indications et s\u00e9curit\u00e9 materno-f\u0153tale"],"prefix":"10.1016","author":[{"given":"Franck","family":"Perrotin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaury","family":"Poque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Le Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pondaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.gofs.2026.07.005_bib0270","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"10","key":"10.1016\/j.gofs.2026.07.005_bib0275","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","author":"Hofmeyr","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"8433","key":"10.1016\/j.gofs.2026.07.005_bib0280","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"issue":"9575","key":"10.1016\/j.gofs.2026.07.005_bib0285","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gofs.2026.07.005_bib0290","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.gofs.2026.07.005_bib0295","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"issue":"1\u20132","key":"10.1016\/j.gofs.2026.07.005_bib0300","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"issue":"3","key":"10.1016\/j.gofs.2026.07.005_bib0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.gofs.2026.07.005_bib0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2026.07.005_bib0315","doi-asserted-by":"crossref","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"issue":"8898","key":"10.1016\/j.gofs.2026.07.005_bib0320","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.gofs.2026.07.005_bib0325","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0330","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2026.07.005_bib0335","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejogrb.2021.05.017","article-title":"Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: a systematic review and meta-analysis","volume":"262","author":"Man","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0340","doi-asserted-by":"crossref","first-page":"e2142343","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10220","key":"10.1016\/j.gofs.2026.07.005_bib0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/humrep\/deh037","article-title":"Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices","volume":"19","author":"Prefumo","year":"2004","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.gofs.2026.07.005_bib0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1503\/cmaj.070430","article-title":"Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis","volume":"178","author":"Cnossen","year":"2008","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0360","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/uog.13275","article-title":"First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women","volume":"43","author":"Velauthar","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0365","first-page":"510","article-title":"Screening with a uterine Doppler in low risk pregnant women followed by low dose aspirin in women with abnormal results: a multicenter randomised controlled trial","volume":"108","author":"Goffinet","year":"2001","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0370","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Randomised comparison of uterine artery Doppler and aspirin (100mg) with placebo in nulliparous women: the Essai R\u00e9gional Aspirine M\u00e8re-Enfant study (Part 2)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gofs.2026.07.005_bib0375","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.218","article-title":"Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks\u2019 gestation","volume":"22","author":"Yu","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.gofs.2026.07.005_bib0380","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S1701-2163(16)34300-6","article-title":"Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis","volume":"31","author":"Bujold","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"issue":"10","key":"10.1016\/j.gofs.2026.07.005_bib0385","doi-asserted-by":"crossref","first-page":"e0275129","DOI":"10.1371\/journal.pone.0275129","article-title":"Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: a double blinded randomized placebo-controlled trial (PERASTUN)","volume":"17","author":"Diguisto","year":"2022","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.gofs.2026.07.005_bib0390","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1055\/s-0038-1675209","article-title":"First-trimester uterine artery Doppler for the prediction of preeclampsia in nulliparous women: the Great Obstetrical Syndrome study","volume":"36","author":"Demers","year":"2019","journal-title":"Am J Perinatol"},{"issue":"7","key":"10.1016\/j.gofs.2026.07.005_bib0395","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1471-0528.2010.02577.x","article-title":"How to interpret randomised trials of test-treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre-eclampsia","volume":"117","author":"Fox","year":"2010","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.gofs.2026.07.005_bib0400","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2026.07.005_bib0405","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"24","key":"10.1016\/j.gofs.2026.07.005_bib0410","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMc1713798","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia [letter]","volume":"377","author":"Sentilhes","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gofs.2026.07.005_bib0415","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/1471-0528.16246","article-title":"External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicentre retrospective cohort study","volume":"127","author":"Brunelli","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.gofs.2026.07.005_bib0420","unstructured":"Randomized study on first-trimester screening for pre-eclampsia (RANSPRE). ClinicalTrials.gov identifier: NCT05521776. [Essai en cours d\u2019inclusion, financement PHRC.] https:\/\/clinicaltrials.gov\/study\/NCT05521776."},{"issue":"2","key":"10.1016\/j.gofs.2026.07.005_bib0425","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajog.2025.10.028","article-title":"Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study","volume":"234","author":"Mans-Gallart","year":"2026","journal-title":"Am J Obstet Gynecol"},{"issue":"2S","key":"10.1016\/j.gofs.2026.07.005_bib0430","doi-asserted-by":"crossref","first-page":"S1222","DOI":"10.1016\/j.ajog.2020.08.018","article-title":"Guidelines\u2014similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension","volume":"226","author":"Scott","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0435","first-page":"3","article-title":"La pr\u00e9-\u00e9clampsie\u00a0: recommandations pour la pratique clinique du Coll\u00e8ge national des gyn\u00e9cologues obst\u00e9triciens fran\u00e7ais","volume":"52","author":"Sentilhes","year":"2024","journal-title":"Gynecol Obstetr Fertil Senol"},{"issue":"12","key":"10.1016\/j.gofs.2026.07.005_bib0440","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0445","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gofs.2026.07.005_bib0450","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NICE guideline NG133. London: NICE; 2019. https:\/\/www.nice.org.uk\/guidance\/ng133."},{"key":"10.1016\/j.gofs.2026.07.005_bib0455","unstructured":"World Health Organization. WHO recommendations on antiplatelet agents for the prevention of pre-eclampsia. Geneva: WHO; 2021. ISBN 978-92-4-003754-0. https:\/\/www.who.int\/publications\/i\/item\/9789240037540."},{"issue":"Suppl. 1","key":"10.1016\/j.gofs.2026.07.005_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0465","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jogc.2022.03.002","article-title":"Guideline No. 426: hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management","volume":"44","author":"Magee","year":"2022","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.gofs.2026.07.005_bib0470","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis and management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"10","key":"10.1016\/j.gofs.2026.07.005_bib0475","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gofs.2026.07.005_bib0480","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajog.2017.12.238","article-title":"Meta-analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gofs.2026.07.005_bib0490","first-page":"465","article-title":"Propensity score analysis of low-dose aspirin and bleeding complications in pregnancy","volume":"63","author":"Souter","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0495","doi-asserted-by":"crossref","first-page":"18467","DOI":"10.1038\/s41598-026-46574-y","article-title":"Aspirin-related hemorrhagic complications in pregnancy: a nationwide French cohort study (ASPREG)","volume":"16","author":"Tsatsaris","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gofs.2026.07.005_bib0500","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.111.1.e77","article-title":"Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation","volume":"111","author":"Leonhardt","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.gofs.2026.07.005_bib0505","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.gofs.2026.07.005_bib0510","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.gofs.2026.07.005_bib0515","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/aogs.14955","article-title":"Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: post hoc analysis of StopPRE trial","volume":"103","author":"Ricart","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gofs.2026.07.005_bib0260","series-title":"D\u00e9veloppement et \u00e9valuation des performances de mod\u00e8les d\u2019apprentissage automatique pour la pr\u00e9diction de la pr\u00e9\u00e9clampsie au premier trimestre de la grossesse [th\u00e8se d\u2019exercice de m\u00e9decine]","author":"Poque","year":"2026"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718926001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718926001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:48:10Z","timestamp":1793018890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718926001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":52,"alternative-id":["S2468718926001881"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2026.07.005","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirine et grossesse \u00e0 l\u2019\u00e8re du d\u00e9pistage pr\u00e9coce au 1er trimestre\u00a0: efficacit\u00e9, indications et s\u00e9curit\u00e9 materno-f\u0153tale","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}